Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
zydus
120 Tablet in Bottle
Abiraterone acetate
Keep in cold place
Delivering To:
Overview
Zybiraa 250Mg Tablet is a hormonal therapy based anticancer medicine used to treat prostate cancer in men. Abiraterone acetate is the generic name of the medicine. It is an anti-androgen medicine which work by blocking the production of male hormone androgen to slow down the progression of cancer. It is only meant for treating prostate cancer in men and should not be prescribed to women. It also contains lactose and sodium, so inform your physician if you are lactose intolerant or on a salt control diet.
Prostate Cancer
Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Zybiraa 250Mg Tablet also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include:
Groin pain
Irregular heart rate
Blood in urine
Yellowing of skin and eyes
Bleeding
Unusual bruising
Swelling of joints
Diarrhea
Constipation
Trouble sleeping
Heartburn
Hot flashes
Contact your doctor immediately if you experience any severe or unusual side effects.
The dosage of Zybiraa 250Mg Tablet is determined by the doctor as per the stage of cancer and other health factors of the patient. The medicine should be taken orally on an empty stomach or can be consumed one hour before or two hours after a meal. In case of an overdose, contact your doctor immediately.
Alcohol
unsafe
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Zybiraa 250Mg Tablet.
Pregnancy
consult your doctor
Do not take Zybiraa 250Mg Tablet during pregnancy, as it is a highly unsafe medicine for the fetus. Also, this medicine is especially designed to treat male-related cancers.
Breast Feeding
consult your doctor
Zybiraa 250Mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby. Also, this medicine is especially designed to treat male-related cancers.
Driving
danger
Zybiraa 250Mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Consumption of Zybiraa 250Mg Tablet should be avoided without informing the doctor if you have any kidney-related issues
Liver
caution
Consumption of Zybiraa 250Mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
It is advisable to avoid missing any dose. In case, you missed a dose of Zybiraa 250mg tablet consult your doctor immediately.
Zybiraa 250mg tablet is an anticancer tablet that is used in the treatment of prostate cancer in men.
Zybiraa 250mg tablet is taken orally every day without food. The doctor decides whether to take it once or twice. The medicine should be taken one hour before or two hours after the meal.
It is advisable to avoid driving and operating heavy machinery as Zybiraa may cause dizziness.
Zybiraa 250mg tablet is a medication for treating prostate cancer in men. Therefore female patients should avoid taking this medicine in case of pregnancy and breastfeeding.
It is advisable to store the Zybiraa 250mg tablets at room temperature at a place below 30°C.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1.Kumar, S., Joshi, A., Takke, A., Varghese, D., Pathak, S., Noronha, V., ... & Gota, V. (2025). Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis. Indian Journal of Medical and Paediatric Oncology.
2. Rehman, Y., & Rosenberg, J. E. (2012). Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer. Drug design, development and therapy, 13-18.
3.Scott, L. J. (2017). Abiraterone acetate: a review in metastatic castration-resistant prostrate cancer. Drugs, 77(14), 1565-1576.
4. Buikin, P., Vologzhanina, A., Novikov, R., Dorovatovskii, P., & Korlyukov, A. (2023). Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding. Pharmaceutics, 15(9), 2180.
5. Salem, M., & Garcia, J. A. (2011). Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer. Current oncology reports, 13(2), 92-96.
zydus
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.